Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]
Anita D’Souza, Mary M. Horowitz(Medical College of Wisconsin), Waleska S. Pérez(Medical College of Wisconsin), Mehdi Hamadani(Medical College of Wisconsin), Saurabh Chhabra(Medical College of Wisconsin), Stephanie J. Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Parameswaran Hari(Medical College of Wisconsin), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Mary Eapen(Medical College of Wisconsin), Patricia Steinert(Medical College of Wisconsin), Mukta Arora(Fairview Health Services), Wael Saber(Medical College of Wisconsin), Stephen R. Spellman(National Marrow Donor Program), Daniel J. Weisdorf(University of Minnesota), Janet Brunner, J. Douglas Rizzo, Marcelo C. Pasquini(Cleveland Clinic), Rachel Phelan(Children's Hospital of Wisconsin), Steven M. Devine(National Marrow Donor Program), Caitrin Fretham(National Marrow Donor Program), Marcie Riches(Medical College of Wisconsin)
Cited by 16
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
|Journal of Clinical Oncology|2006|2k